Related Experiment Video
Updated: Mar 27, 2026
04:12
Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid
Published on: January 19, 2024
1.8K
Methotrexate: practical use in dermatology.
Marco Diani1, Vincenzo Grasso, Gianfranco Altomare
1Department of Dermatology and Venereology, I.R.C.C.S. Istituto Ortopedico Galeazzi, University of Milan, Milan, Italy - marco.diani@hotmail.it.
Summary
Methotrexate (MTX) is a widely used drug for various skin conditions due to its anti-inflammatory and immunosuppressant properties. Ongoing research aims to optimize its use and efficacy in dermatology, alone or with other treatments.
Area of Science:
- Dermatology
- Pharmacology
Background:
- Methotrexate (MTX) is a well-established anti-inflammatory, anti-proliferative, and immunosuppressant medication.
- It is recognized for its efficacy, safety, and ease of use in treating numerous skin diseases, initially for psoriasis.
Purpose of the Study:
- To update the understanding of Methotrexate's applications in dermatology.
- To review current scientific literature and clinical experience regarding MTX.
- To explore strategies for enhancing MTX manageability and evaluating its efficacy in monotherapy and combination treatments.
Main Methods:
- Systematic review of scientific literature.
- Analysis of clinical experience.
- Consultation of official treatment guidelines.
Main Results:
- Methotrexate is a versatile and safe therapeutic option for a broad spectrum of dermatological conditions.
- Continuous research focuses on improving Methotrexate treatment strategies and assessing its effectiveness.
Conclusions:
- Methotrexate remains a key agent in dermatological therapy.
- Further research is essential to refine Methotrexate's clinical utility and patient management in treating skin diseases.
Related Concept Videos
01:29Therapeutic Drug Monitoring: Affecting Factors
328
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
328
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
663
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
663
01:27Acne Infection
40
Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
40
01:17Phase II Reactions: Methylation Reactions
871
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
871
01:16Therapeutic Drug Monitoring: Overview and Classification
510
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
510
01:18Transdermal Drug Delivery Systems
135
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
135